$WAY

Waystar (WAY) Q2 2026 Earnings Call Transcript

Waystar (WAY) reported Q2 2026 demand for its revenue cycle platform, citing client expansion and platform consolidation. Clients over $100k trailing revenue rose 15% to 1,453, with net revenue retention of 108%. The company cited $1M-plus ACV bookings, including ProMedica’s nearly $10M in billing opportunities and other incremental revenue claims.

Original reporting
Published Aug 9, 2026, 8:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 9, 2026, 8:16 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Waystar (WAY) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$WAYBullishLow
01

Why it matters

The key trading takeaway is management’s continued emphasis on platform consolidation, cross-sell (Iodine), and AI-driven denial prevention, supported by retention and bookings commentary plus named customer examples.

02

Market read

For traders, the transcript reinforces a positive demand and expansion narrative, but the excerpt does not show a clear new guidance shock or a specific financial datapoint that would materially reset expectations.

03

What to watch

Incremental revenue expectations are described qualitatively (e.g., “more than $1 million” and “7 figures”), so traders may discount impact until confirmed in reported revenue, bookings, and forward guidance.

Relevance 4/10Novelty 4/10Timing: during the Q2 2026 earnings call transcript (pre-market/market open window)

Background

The article is a transcript of Waystar’s Q2 2026 earnings call, focused on demand, bookings, retention, and AI product monetization within revenue-cycle workflows.

Company-level read

Ticker impact

$WAYBullishMedium confidence
Context

Waystar’s Q2 2026 call highlights bookings momentum, including double-digit $1M-plus ACV bookings and expanding multi-solution deployments.

Expected impact

Near-term sentiment bias to the upside, but likely limited incremental price discovery versus what investors already expect from an earnings transcript.

Evidence & confidence

The transcript provides qualitative demand and retention metrics plus specific customer examples, but the excerpt does not include fresh financial guidance numbers or a clear surprise datapoint.

Market effects

Supports the narrative that revenue-cycle software buyers are consolidating from point solutions to connected platforms, reinforcing demand for workflow and AI-enabled denial prevention.

No clear regional market impact beyond customer geography examples.

Primarily US healthcare payment workflow dynamics; limited direct global read-through from the excerpt.

Counterpoint

The excerpt is heavy on customer wins and operational claims, but without the full financial tables or explicit guidance changes, the market may treat it as reiteration rather than a new earnings surprise.

Key entities

  • Waystar

    Provider of revenue-cycle management software and AI-enabled payment workflow solutions; subject of the earnings call transcript.

  • ProMedica

    Hospital and physician network cited for uncovering nearly $10 million in previously unidentified billing opportunities using Waystar’s patient insurance coverage solution.

  • KLAS Research

    Cited for a report reflecting the shift toward revenue cycle management suites and platform consolidation.

Related articles

$WAYMedAI 9/10

Waystar Holding Corp. (WAY): Results of Operations and Financial Condition

Waystar Holding Corp. (WAY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 way072926-8xkex991.htm EX-99.1 Document Waystar Reports Second Quarter 2026 Results Q2 revenue of $319.7M, up 18% YoY Q2 net income of $40.9M and non-GAAP net income of $83.3M Q2 net income margin of 13%; adjusted EBITDA margin of 43% Raising revenue and adjusted EBITDA

$HMNMed

Horace Mann Educators Q2 Earnings Call Highlights

Horace Mann (NYSE:HMN) reported Q2 call highlights. Management said auto frequency and severity trends were favorable and liability losses mid-single digits. It cut its full-year catastrophe-loss assumption to about $75M from $90M, while lowering total net investment income outlook to $465M-$475M. Revenue rose 8% YoY; life sales +20%.

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.